Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Kineret Rosenblatt"'
Autor:
Michal Yalon, Liron Tuval-Kochen, David Castel, Itai Moshe, Inbal Mazal, Osher Cohen, Camila Avivi, Kineret Rosenblatt, Sarit Aviel-Ronen, Ginette Schiby, Joachim Yahalom, Ninette Amariglio, Raphael Pfeffer, Yaacov R Lawrence, Amos Toren, Gideon Rechavi, Shoshana Paglin
Publikováno v:
PLoS ONE, Vol 11, Iss 8, p e0161799 (2016)
[This corrects the article DOI: 10.1371/journal.pone.0155711.].
Externí odkaz:
https://doaj.org/article/53a6bd4b59a64f0c967b0678d62e1ce5
Autor:
Michal Yalon, Liron Tuval-Kochen, David Castel, Itai Moshe, Inbal Mazal, Osher Cohen, Camila Avivi, Kineret Rosenblatt, Sarit Aviel-Ronen, Ginette Schiby, Joachim Yahalom, Ninette Amariglio, Raphael Pfeffer, Yaacov Lawrence, Amos Toren, Gideon Rechavi, Shoshana Paglin
Publikováno v:
PLoS ONE, Vol 11, Iss 5, p e0155711 (2016)
Inhibitors of poly[ADP-ribose] polymerase 1 (PARPis) show promise for treatment of cancers which lack capacity for homologous recombination repair (HRR). However, new therapeutic strategies are required in order to overcome innate and acquired resist
Externí odkaz:
https://doaj.org/article/46c1ad8125414ba7817d1be1647f2e85
Autor:
Anat Biegon, Barbara S. Slusher, Alcino J. Silva, Dana Atrakchi-Baranes, Kineret Rosenblatt, Efrat L. Kesner, Esther Shohami, Yael Friedman Levi, Sigal Liraz-Zaltsman
Publikováno v:
Journal of Neurotrauma. 35:1667-1680
Cognitive deficits, especially memory loss, are common and devastating neuropsychiatric sequelae of traumatic brain injury (TBI). The deficits may persist for years and may be accompanied by increased risk of developing early- onset dementia. Past at
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f8157e4b20d6d749daef2c6e8eb4e8b8
https://doi.org/10.1089/neu.2017.5561
https://doi.org/10.1089/neu.2017.5561
Autor:
Liron Tuval-Kochen, Inbal Mazal, David Castel, Ginette Schiby, Joachim Yahalom, Shoshana Paglin, Osher Cohen, Itai Moshe, Ninette Amariglio, Raphael Pfeffer, Yaacov Richard Lawrence, Kineret Rosenblatt, Amos Toren, Sarit Aviel-Ronen, Gideon Rechavi, Camila Avivi, Michal Yalon
Publikováno v:
PLoS ONE
PLoS ONE, Vol 11, Iss 5, p e0155711 (2016)
PLoS ONE, Vol 11, Iss 5, p e0155711 (2016)
Inhibitors of poly[ADP-ribose] polymerase 1 (PARPis) show promise for treatment of cancers which lack capacity for homologous recombination repair (HRR). However, new therapeutic strategies are required in order to overcome innate and acquired resist
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b2e7acf29f1a51465b951235f5435f93
http://europepmc.org/articles/PMC4873128
http://europepmc.org/articles/PMC4873128
Autor:
Ninette Amariglio, Raphael Pfeffer, Yaacov Richard Lawrence, Inbal Mazal, Kineret Rosenblatt, Amos Toren, Shoshana Paglin, Gideon Rechavi, Osher Cohen, Ginette Schiby, Joachim Yahalom, Itai Moshe, Michal Yalon, Sarit Aviel-Ronen, Liron Tuval-Kochen, Camila Avivi, David Castel
Publikováno v:
PLoS ONE
PLoS ONE, Vol 11, Iss 8, p e0161799 (2016)
PLoS ONE, Vol 11, Iss 8, p e0161799 (2016)
Inhibitors of poly[ADP-ribose] polymerase 1 (PARPis) show promise for treatment of cancers which lack capacity for homologous recombination repair (HRR). However, new therapeutic strategies are required in order to overcome innate and acquired resist
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d2bcdf7b10aaf56ff4fdb0d7c65a609d
https://doi.org/10.1371/journal.pone.0161799
https://doi.org/10.1371/journal.pone.0161799